vs

Side-by-side financial comparison of KALTURA INC (KLTR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $45.5M, roughly 1.7× KALTURA INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $3.5M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.8%).

Kaltura, Inc. is a New York-based software company founded in 2006. It operates in several major markets: webinars and virtual events, enterprise video content management and online video platform (OVP), educational technology, and Cloud TV software, and offers products such as video portal, LMS and CMS extension, virtual event and webinar platform, and TV streaming app.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

KLTR vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.7× larger
PBYI
$75.5M
$45.5M
KLTR
Growing faster (revenue YoY)
PBYI
PBYI
+27.9% gap
PBYI
27.7%
-0.1%
KLTR
More free cash flow
PBYI
PBYI
$10.9M more FCF
PBYI
$14.4M
$3.5M
KLTR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
0.8%
KLTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KLTR
KLTR
PBYI
PBYI
Revenue
$45.5M
$75.5M
Net Profit
$-575.0K
Gross Margin
72.4%
69.3%
Operating Margin
1.9%
22.7%
Net Margin
-1.3%
Revenue YoY
-0.1%
27.7%
Net Profit YoY
91.3%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KLTR
KLTR
PBYI
PBYI
Q4 25
$45.5M
$75.5M
Q3 25
$43.9M
$54.5M
Q2 25
$44.5M
$52.4M
Q1 25
$47.0M
$46.0M
Q4 24
$45.6M
$59.1M
Q3 24
$44.3M
$80.5M
Q2 24
$44.0M
$47.1M
Q1 24
$44.8M
$43.8M
Net Profit
KLTR
KLTR
PBYI
PBYI
Q4 25
$-575.0K
Q3 25
$-2.6M
$8.8M
Q2 25
$-7.8M
$5.9M
Q1 25
$-1.1M
$3.0M
Q4 24
$-6.6M
Q3 24
$-3.6M
$20.3M
Q2 24
$-10.0M
$-4.5M
Q1 24
$-11.1M
$-4.8M
Gross Margin
KLTR
KLTR
PBYI
PBYI
Q4 25
72.4%
69.3%
Q3 25
70.0%
77.7%
Q2 25
70.2%
76.5%
Q1 25
69.7%
77.1%
Q4 24
70.8%
76.4%
Q3 24
66.7%
63.9%
Q2 24
65.1%
77.4%
Q1 24
63.9%
75.5%
Operating Margin
KLTR
KLTR
PBYI
PBYI
Q4 25
1.9%
22.7%
Q3 25
-3.4%
17.6%
Q2 25
-6.2%
12.7%
Q1 25
-3.4%
8.7%
Q4 24
-8.3%
22.6%
Q3 24
-10.1%
27.4%
Q2 24
-19.4%
-4.6%
Q1 24
-16.3%
-5.3%
Net Margin
KLTR
KLTR
PBYI
PBYI
Q4 25
-1.3%
Q3 25
-6.0%
16.2%
Q2 25
-17.4%
11.2%
Q1 25
-2.4%
6.5%
Q4 24
-14.5%
Q3 24
-8.1%
25.2%
Q2 24
-22.7%
-9.6%
Q1 24
-24.8%
-11.0%
EPS (diluted)
KLTR
KLTR
PBYI
PBYI
Q4 25
$0.26
Q3 25
$0.02
$0.17
Q2 25
$-0.05
$0.12
Q1 25
$0.06
Q4 24
$0.40
Q3 24
$0.02
$0.41
Q2 24
$-0.07
$-0.09
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KLTR
KLTR
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$51.9M
$97.5M
Total DebtLower is stronger
$29.3M
$22.7M
Stockholders' EquityBook value
$6.3M
$130.3M
Total Assets
$164.7M
$216.3M
Debt / EquityLower = less leverage
4.63×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KLTR
KLTR
PBYI
PBYI
Q4 25
$51.9M
$97.5M
Q3 25
$72.2M
$94.4M
Q2 25
$71.2M
$96.0M
Q1 25
$62.9M
$93.2M
Q4 24
$81.3M
$101.0M
Q3 24
$77.7M
$96.7M
Q2 24
$68.3M
$96.8M
Q1 24
$68.9M
$107.2M
Total Debt
KLTR
KLTR
PBYI
PBYI
Q4 25
$29.3M
$22.7M
Q3 25
$30.6M
$34.0M
Q2 25
$31.3M
$45.3M
Q1 25
$31.9M
$56.7M
Q4 24
$68.0M
Q3 24
$33.3M
$79.3M
Q2 24
$33.7M
$90.7M
Q1 24
$34.1M
$102.0M
Stockholders' Equity
KLTR
KLTR
PBYI
PBYI
Q4 25
$6.3M
$130.3M
Q3 25
$17.7M
$115.3M
Q2 25
$17.0M
$104.7M
Q1 25
$22.7M
$97.1M
Q4 24
$24.4M
$92.1M
Q3 24
$24.1M
$71.1M
Q2 24
$23.5M
$48.5M
Q1 24
$25.1M
$51.0M
Total Assets
KLTR
KLTR
PBYI
PBYI
Q4 25
$164.7M
$216.3M
Q3 25
$172.6M
$202.9M
Q2 25
$169.4M
$194.9M
Q1 25
$172.8M
$196.2M
Q4 24
$181.3M
$213.3M
Q3 24
$178.6M
$220.7M
Q2 24
$171.3M
$205.0M
Q1 24
$173.1M
$214.1M
Debt / Equity
KLTR
KLTR
PBYI
PBYI
Q4 25
4.63×
0.17×
Q3 25
1.73×
0.30×
Q2 25
1.85×
0.43×
Q1 25
1.41×
0.58×
Q4 24
0.74×
Q3 24
1.38×
1.12×
Q2 24
1.43×
1.87×
Q1 24
1.36×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KLTR
KLTR
PBYI
PBYI
Operating Cash FlowLast quarter
$3.6M
$14.4M
Free Cash FlowOCF − Capex
$3.5M
$14.4M
FCF MarginFCF / Revenue
7.7%
19.1%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$13.9M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KLTR
KLTR
PBYI
PBYI
Q4 25
$3.6M
$14.4M
Q3 25
$9.3M
$9.7M
Q2 25
$2.7M
$14.1M
Q1 25
$-1.0M
$3.6M
Q4 24
$4.3M
$15.6M
Q3 24
$10.7M
$11.0M
Q2 24
$-1.6M
$1.0M
Q1 24
$-1.1M
$11.2M
Free Cash Flow
KLTR
KLTR
PBYI
PBYI
Q4 25
$3.5M
$14.4M
Q3 25
$9.2M
$9.7M
Q2 25
$2.5M
$14.1M
Q1 25
$-1.3M
$3.6M
Q4 24
$4.2M
$15.6M
Q3 24
$10.6M
$11.0M
Q2 24
$-1.8M
$1.0M
Q1 24
$-1.2M
FCF Margin
KLTR
KLTR
PBYI
PBYI
Q4 25
7.7%
19.1%
Q3 25
20.9%
17.7%
Q2 25
5.7%
26.8%
Q1 25
-2.9%
7.7%
Q4 24
9.2%
26.4%
Q3 24
23.9%
13.7%
Q2 24
-4.2%
2.1%
Q1 24
-2.8%
Capex Intensity
KLTR
KLTR
PBYI
PBYI
Q4 25
0.3%
0.0%
Q3 25
0.3%
0.0%
Q2 25
0.3%
0.0%
Q1 25
0.6%
0.1%
Q4 24
0.2%
0.0%
Q3 24
0.2%
0.0%
Q2 24
0.5%
0.0%
Q1 24
0.2%
0.0%
Cash Conversion
KLTR
KLTR
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KLTR
KLTR

Subscription$42.7M94%
Professional Services$2.9M6%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons